Nexgel NXGL
NASDAQ NXGL
$3.58 +0.06 (+1.70%)
At close: Nov 10, 2026 · 4:00 PM EST

Nexgel (NXGL) EPS (Basic) (2018 - 2026)

Updated

Nexgel (NXGL) reported EPS (Basic) of -$0.40 for Q2 2026, compared with -$0.09 a year earlier.

Analysis

Nexgel (NXGL) EPS (Basic) (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nexgel's EPS (Basic) came in at -$0.66; for FY2025, it came in at -$0.38.

  • By year, EPS (Basic) came in at -$0.50 in FY2024, -$0.56 in FY2023, -$0.85 in FY2022 and -$1.45 in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly EPS (Basic) since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Iqvia Holdings 45.39 Bn 36.65 Bn 1.50 Bn 2.13
2 Medpace Holdings 18.59 Bn 16.24 Bn 223.89 Mn 4.92
3 Charles River Laboratories International 16.59 Bn 15.79 Bn 357.87 Mn 6.97
4 Icon 15.81 Bn 12.58 Bn 491.83 Mn 1.56
5 Fortrea Holdings 2.06 Bn 1.35 Bn 139.50 Mn 0.01
6 Ginkgo Bioworks Holdings 758.79 Mn -3.29 Mn 18.44 Mn -0.75
7 Evotec SE 603.77 Mn -1.27 Bn - -
8 Champions Oncology 68.48 Mn 44.13 Mn 7.70 Mn -0.03
9 MindWalk Holdings 48.71 Mn 12.36 Mn 1.61 Mn -0.09
10 Nexgel 1.49 Mn -4.33 Mn 1.11 Mn -8.07
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.07
Dec 31, 2025 -2.47
Sep 30, 2025 -1.64
Jun 30, 2025 -1.74
Mar 31, 2025 -1.86
Dec 31, 2024 -2.61
Sep 30, 2024 -2.11
Jun 30, 2024 -2.83
Mar 31, 2024 -2.85
Dec 31, 2023 -3.87
Sep 30, 2023 -1.92
Jun 30, 2023 -2.45
Mar 31, 2023 -2.91
Dec 31, 2022 -2.32
Sep 30, 2022 -4.40
Jun 30, 2022 -3.71
Mar 31, 2022 -6.59
Dec 31, 2021 -11.00
Sep 30, 2021 -7.67
Jun 30, 2021 -5.61
API Access

Nexgel EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=NXGL&period=max&api_key=YOUR_API_KEY